{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-009843","form_type":"8-K","ticker":"AGIO","cik":"0001439222","company_name":"AGIOS PHARMACEUTICALS, INC.","filed_at":"2022-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.491139+00:00","generated_at":"2026-06-27T17:53:33.281559+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Agios sets 2022 annual meeting for June 21; stockholder deadlines announced","bullets":["2022 annual meeting to be held virtually on June 21, 2022.","Deadline for Rule 14a-8 stockholder proposals for proxy inclusion is January 28, 2022.","Other proposals or director nominations must be submitted between January 20 and February 19, 2022.","Meeting date is more than 30 days after 2021 annual meeting, triggering adjusted deadline rules.","Proposals must comply with applicable laws and company bylaws."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-009843","json":"https://secwatch.observer/filing/0001193125-22-009843.json","markdown":"https://secwatch.observer/filing/0001193125-22-009843.md","text":"https://secwatch.observer/filing/0001193125-22-009843.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439222/000119312522009843/0001193125-22-009843-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439222/000119312522009843/d295722d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T17:53:33.281559+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}